TipRanks
Go Ultimate55% OFF

Harmony Biosciences Holdings (HRMY) Revenue

Harmony Biosciences Holdings Revenue

Harmony Biosciences Holdings had a revenue of 261.28M in the quarter ending Jun 30, 2026, with 21.31%. This bring the company's revenue in the last twelve months to 959.90M, Increased 6.76%. In the fiscal year ending Dec 31, 2025, Harmony Biosciences Holdings had annual revenue of 868.45M with 21.51% growth.

Revenue (ttm)
959.90M
Revenue Growth
24.25%
P/S Ratio
2.60
Revenue/Employee
$2,964,003
Employees
293
Market Cap
$2.26B

Revenue Chart

Harmony Biosciences Holdings Revenue - Annual

0200M400M600M800M1B6.00M159.74M305.44M437.86M582.02M714.73M868.45M20182019202020212022202320242025
Revenue History
Download to Excel
HRMY revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025868.45M153.72M21.51%
Dec 31, 2024714.73M132.71M22.80%
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.41M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020159.74M153.75M2564.59%
Dec 31, 20196.00M6.00M―
Dec 31, 20180.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
HRMY959.90M
XENE0.00
ZVRA136.07M
STOK27.59M
RAPP20.00M
APMD―